Gimbel Howard V, Ziémba Steven L
Gimbel Eye Centre, Calgary, Alberta, Canada.
J Cataract Refract Surg. 2002 May;28(5):883-6. doi: 10.1016/s0886-3350(01)01098-7.
A 48-year-old woman presented with a manifest refraction of -9.25 -2.25 x 98 that resulted in a best corrected visual acuity (BCVA) of 20/20(-2) in the right eye. She was contact lens intolerant but was not a good candidate for laser in situ keratomileusis because of a thin cornea. A phakic posterior chamber intraocular lens (IOL) with a toric optic was implanted with no operative complications. One day after surgery, the uncorrected visual acuity (UCVA) was 20/15. Five months postoperatively, the UCVA in the operated eye was 20/15 with a manifest refraction of +0.25 -0.25 x 60 and a BCVA of 20/15. No changes to the crystalline lens or anterior lens capsule were seen. This is the first report of implantation of a toric phakic IOL in North America.
一名48岁女性，右眼明显屈光不正为-9.25 -2.25×98，最佳矫正视力（BCVA）为20/20（-2）。她不耐受隐形眼镜，但由于角膜薄，不适合准分子原位角膜磨镶术。植入了一枚带散光光学部的有晶状体眼后房型人工晶状体（IOL），手术无并发症。术后一天，裸眼视力（UCVA）为20/15。术后五个月，手术眼的UCVA为20/15，明显屈光不正为+0.25 -0.25×60，BCVA为20/15。晶状体及晶状体前囊未见变化。这是北美首例关于植入散光有晶状体眼IOL的报道。
